ICU MEDICAL INC/DE (ICUI)

Latest Insider Confidence Score

2025Q4

48.1
Bearish

Company insider confidence (by quarter)

2012Q3 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Smiths Group Plc Other 1,670,000 Mar 1, 2024
Smiths Group International Holdings Ltd Other 1,670,000 Mar 1, 2024
Lopez George A Director 885,321 Mar 14, 2024
Jain Vivek CEO 152,339 Sep 15, 2025
Swinney Robert S Director 21,593 Jul 28, 2017

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 25, 2025 Nov 25, 2025 Woolson Daniel VP, GM-Infusion Capital Sell 20.0 -2,897 -20.41% ✗ $441.4K
Nov 11, 2025 Nov 12, 2025 FINNEY ELISHA W Director Sell 22.5 -1,285 -24.34% ✗ $180.4K
Nov 11, 2025 Nov 12, 2025 Sanzone Virginia Ruth VP, General Counsel Sell 22.5 -930 -14.56% ✗ $132.4K
Sep 12, 2025 Sep 15, 2025 Jain Vivek CEO Neutral 52.5 - 0.00% ✗ -
Aug 27, 2025 Aug 27, 2025 Greenberg David C. Director Buy 95.0 +1,200 16.53% ✗ $151.7K
Aug 14, 2025 Aug 14, 2025 Jain Vivek CEO Buy 100.0 +21,929 11.14% ✗ $2.5M
May 30, 2025 May 30, 2025 Sanzone Virginia Ruth VP, General Counsel Sell 22.5 -700 -9.88% ✗ $93.5K
May 27, 2025 May 28, 2025 Voigtlander Christian B. COO Sell 17.5 -9,930 -46.12% ✗ $1.3M
May 22, 2025 May 23, 2025 Voigtlander Christian B. COO Sell 17.5 -9,918 -51.85% ✗ $1.3M
May 20, 2025 May 21, 2025 Voigtlander Christian B. COO Sell 17.5 -9,788 -59.06% ✗ $1.3M
May 19, 2025 May 20, 2025 FINNEY ELISHA W Director Sell 22.5 -600 -15.58% ✗ $83.4K
May 16, 2025 May 19, 2025 Voigtlander Christian B. COO Sell 17.5 -11,110 -69.93% ✗ $1.5M
May 14, 2025 May 15, 2025 Voigtlander Christian B. COO Sell 17.5 -11,111 -69.93% ✗ $1.5M
May 15, 2025 May 15, 2025 Sousa Ben Chief Information Officer Sell 20.0 -2,000 -80.68% ✗ $274.7K
May 13, 2025 May 14, 2025 FINNEY ELISHA W Director Neutral 52.5 - 0.00% ✗ -
May 13, 2025 May 13, 2025 KENNEDY KOLLEEN T Director Neutral 52.5 - 0.00% ✗ -
May 13, 2025 May 13, 2025 Hoffmeister David F Director Neutral 52.5 - 0.00% ✗ -
May 13, 2025 May 13, 2025 Abbey Donald Director Neutral 52.5 - 0.00% ✗ -
May 13, 2025 May 13, 2025 Hernandez Laurie Director Neutral 52.5 - 0.00% ✗ -
May 13, 2025 May 13, 2025 Greenberg David C. Director Sell 20.0 -1,942 -21.10% ✗ $279K
Mar 15, 2025 Mar 17, 2025 Bonnell Brian Michael CFO Neutral 52.5 - 0.00% ✗ -
Mar 15, 2025 Mar 17, 2025 Jain Vivek CEO Sell 20.0 -2,688 -1.35% ✗ $385.6K
Mar 15, 2025 Mar 17, 2025 Sanzone Virginia Ruth VP, General Counsel Sell 22.5 -898 -11.25% ✗ $128.8K
Mar 15, 2025 Mar 17, 2025 Sousa Ben Chief Information Officer Sell 22.5 -716 -22.41% ✗ $102.7K
Mar 15, 2025 Mar 17, 2025 Voigtlander Christian B. COO Sell 20.0 -1,792 -42.86% ✗ $257.1K
Mar 15, 2025 Mar 17, 2025 Woolson Daniel VP, GM-Infusion Capital Sell 22.5 -1,294 -8.35% ✗ $185.6K
Mar 7, 2025 Mar 14, 2025 Jain Vivek CEO Neutral 52.5 - 0.00% ✗ -
Mar 7, 2025 Mar 10, 2025 Sanzone Virginia Ruth VP, General Counsel Sell 20.0 -2,384 -17.43% ✗ $338.5K
Mar 7, 2025 Mar 10, 2025 Jain Vivek CEO Neutral 37.5 -1,775 -0.92% ✗ -
Mar 7, 2025 Mar 10, 2025 Sousa Ben Chief Information Officer Sell 22.5 -810 -19.31% ✗ $115K
Mar 7, 2025 Mar 10, 2025 Woolson Daniel VP, GM-Infusion Capital Sell 22.5 -1,420 -5.60% ✗ $201.6K
Mar 7, 2025 Mar 10, 2025 Voigtlander Christian B. COO Sell 22.5 -1,213 -56.52% ✗ $172.2K
Mar 7, 2025 Mar 10, 2025 Bonnell Brian Michael CFO Neutral 52.5 - 0.00% ✗ -
Jan 2, 2025 Jan 2, 2025 Jain Vivek CEO Sell 47.5 -1,373 -0.71% ✓ $213.5K
Dec 6, 2024 Dec 6, 2024 Woolson Daniel VP, GM-Infusion Capital Sell 20.0 -2,241 -17.10% ✗ $350.2K
Dec 2, 2024 Dec 2, 2024 Jain Vivek CEO Sell 27.5 -12,000 -5.85% ✓ $2M
Nov 27, 2024 Nov 27, 2024 Greenberg David C. Director Sell 22.5 -972 -14.93% ✗ $153.7K
Nov 27, 2024 Nov 27, 2024 Voigtlander Christian B. COO Sell 22.5 -1,430 -100.00% ✗ $225.9K
Nov 25, 2024 Nov 26, 2024 Voigtlander Christian B. COO Sell 17.5 -9,681 -97.92% ✗ $1.6M
Nov 1, 2024 Nov 4, 2024 Jain Vivek CEO Sell 27.5 -12,000 -5.85% ✓ $2.1M
Oct 1, 2024 Oct 1, 2024 Jain Vivek CEO Sell 27.5 -12,000 -5.85% ✓ $2.1M
Sep 3, 2024 Sep 3, 2024 Jain Vivek CEO Sell 36.3 -12,000 -2.90% ✓ $2M
Aug 30, 2024 Aug 30, 2024 Woolson Daniel VP, GM-Infusion Capital Sell 20.0 -2,502 -16.03% ✗ $408.4K
Aug 16, 2024 Aug 16, 2024 Jain Vivek CEO Sell 27.5 -12,000 -5.85% ✓ $1.9M
Aug 8, 2024 Aug 8, 2024 Sanzone Virginia Ruth VP, General Counsel Sell 7.5 -2,050 -31.38% ✓ $295.4K
May 30, 2024 May 30, 2024 Voigtlander Christian B. COO Sell 17.5 -12,539 -100.00% ✗ $1.3M
May 16, 2024 May 16, 2024 FINNEY ELISHA W Director Sell 26.3 -300 -12.35% ✗ $31.5K
May 15, 2024 May 15, 2024 Hoffmeister David F Director Neutral 52.5 - 0.00% ✗ -
May 15, 2024 May 15, 2024 KENNEDY KOLLEEN T Director Neutral 52.5 - 0.00% ✗ -
May 15, 2024 May 15, 2024 Abbey Donald Director Neutral 52.5 - 0.00% ✗ -
May 15, 2024 May 15, 2024 FINNEY ELISHA W Director Neutral 52.5 - 0.00% ✗ -
May 15, 2024 May 15, 2024 Greenberg David C. Director Neutral 52.5 - 0.00% ✗ -
May 15, 2024 May 15, 2024 Hernandez Laurie Director Neutral 52.5 - 0.00% ✗ -
May 10, 2024 May 10, 2024 Sousa Ben Chief Information Officer Sell 22.5 -2,000 -60.26% ✗ $211.1K
Mar 15, 2024 Mar 18, 2024 Voigtlander Christian B. COO Sell 22.5 -1,780 -12.43% ✗ $174.6K
Mar 15, 2024 Mar 18, 2024 Woolson Daniel VP, GM-Infusion Capital Sell 22.5 -1,294 -7.66% ✗ $126.9K
Mar 15, 2024 Mar 18, 2024 Sousa Ben Chief Information Officer Sell 26.3 -463 -12.24% ✗ $45.4K
Mar 15, 2024 Mar 18, 2024 Sanzone Virginia Ruth VP, General Counsel Sell 22.5 -890 -11.99% ✗ $87.3K
Mar 15, 2024 Mar 18, 2024 Jain Vivek CEO Sell 20.0 -2,671 -1.36% ✗ $262K
Mar 15, 2024 Mar 18, 2024 Bonnell Brian Michael CFO Sell 22.5 -1,780 -6.66% ✗ $174.6K
Mar 15, 2024 Mar 15, 2024 Woolson Daniel VP, GM-Infusion Capital Sell 22.5 -791 -5.36% ✗ $77.7K
Mar 14, 2024 Mar 14, 2024 LOPEZ GEORGE A Director Sell 30.0 -7,978 -0.66% ✗ $812.7K
Mar 12, 2024 Mar 14, 2024 LOPEZ GEORGE A Director Sell 47.5 -1,522 -0.17% ✗ $154.5K
Mar 11, 2024 Mar 13, 2024 LOPEZ GEORGE A Director Sell 37.5 -3,412 -0.28% ✗ $351.5K
Mar 7, 2024 Mar 11, 2024 Woolson Daniel VP, GM-Infusion Capital Sell 20.0 -3,884 -9.09% ✗ $408.6K
Mar 7, 2024 Mar 11, 2024 Sousa Ben Chief Information Officer Sell 22.5 -1,317 -21.10% ✗ $138.6K
Mar 7, 2024 Mar 11, 2024 Voigtlander Christian B. COO Sell 17.5 -13,444 -33.57% ✗ $1.4M
Mar 7, 2024 Mar 11, 2024 Bonnell Brian Michael CFO Sell 17.5 -13,444 -14.99% ✗ $1.4M
Mar 7, 2024 Mar 11, 2024 Jain Vivek CEO Sell 17.5 -18,305 -3.70% ✗ $1.9M
Mar 7, 2024 Mar 11, 2024 Sanzone Virginia Ruth VP, General Counsel Sell 20.0 -8,662 -26.68% ✗ $909.1K
Mar 4, 2024 Mar 11, 2024 LOPEZ GEORGE A Director Sell 17.5 -41,377 -3.32% ✗ $4.4M
Mar 4, 2024 Mar 5, 2024 Voigtlander Christian B. COO Sell 17.5 -13,603 -100.00% ✗ $1.5M
Feb 29, 2024 Mar 1, 2024 SMITHS GROUP PLC Other Sell 15.0 -830,000 -33.20% ✗ $88M
Feb 29, 2024 Mar 1, 2024 Smiths Group International Holdings Ltd Other Sell 15.0 -830,000 -33.20% ✗ $88M
Feb 26, 2024 Sousa Ben Chief Information Officer Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 Jain Vivek CEO Sell 15.0 -120,027 -40.54% ✗ $12.5M
Dec 1, 2023 Dec 1, 2023 Woolson Daniel VP, GM-Infusion Capital Sell 22.5 -1,729 -14.90% ✗ $152.2K
Sep 8, 2023 Sep 11, 2023 Voigtlander Christian B. COO Sell 20.0 -6,850 -33.49% ✗ $883.9K
Jul 12, 2023 Jul 14, 2023 Jain Vivek CEO Sell 3.8 -30,000 -26.39% ✓ $5.4M
Jun 14, 2023 Jun 15, 2023 Jain Vivek CEO Sell 22.5 -30,000 -9.06% ✓ $5.7M
Jun 7, 2023 Jun 7, 2023 FINNEY ELISHA W Director Sell 28.8 -194 -11.58% ✓ $36.9K
Jun 2, 2023 Jun 5, 2023 Jain Vivek CEO Neutral 52.5 -85 -0.10% ✗ -
May 17, 2023 May 18, 2023 Sanzone Virginia Ruth VP, General Counsel Neutral 52.5 - 0.00% ✗ -
May 17, 2023 May 18, 2023 Bonnell Brian Michael CFO Neutral 52.5 - 0.00% ✗ -
May 17, 2023 May 18, 2023 Voigtlander Christian B. COO Neutral 52.5 - 0.00% ✗ -
May 17, 2023 May 18, 2023 Jain Vivek CEO Neutral 52.5 - 0.00% ✗ -
May 17, 2023 May 18, 2023 KENNEDY KOLLEEN T Director Neutral 52.5 - 0.00% ✗ -
May 17, 2023 May 18, 2023 Hoffmeister David F Director Neutral 52.5 - 0.00% ✗ -
May 17, 2023 May 18, 2023 FINNEY ELISHA W Director Neutral 52.5 - 0.00% ✗ -
May 17, 2023 May 18, 2023 Abbey Donald Director Neutral 52.5 - 0.00% ✗ -
May 17, 2023 May 18, 2023 Hernandez Laurie Director Neutral 52.5 - 0.00% ✗ -
May 17, 2023 May 18, 2023 Greenberg David C. Director Neutral 52.5 - 0.00% ✗ -
Apr 11, 2023 Apr 11, 2023 Sanzone Virginia Ruth VP, General Counsel Sell 36.3 -250 -5.07% ✓ $43.8K
Apr 5, 2023 Apr 5, 2023 Sanzone Virginia Ruth VP, General Counsel Sell 28.8 -458 -8.50% ✓ $77.9K
Mar 6, 2023 Mar 8, 2023 Woolson Daniel VP, GM-Infusion Capital Sell 20.0 -1,948 -5.73% ✗ $308K
Mar 6, 2023 Mar 8, 2023 Sanzone Virginia Ruth VP, General Counsel Sell 20.0 -2,599 -16.15% ✗ $410.9K
Mar 6, 2023 Mar 8, 2023 Voigtlander Christian B. COO Sell 17.5 -7,712 -9.22% ✗ $1.2M
Mar 6, 2023 Mar 8, 2023 Jain Vivek CEO Sell 17.5 -9,217 -6.03% ✗ $1.5M
Mar 6, 2023 Mar 8, 2023 Bonnell Brian Michael CFO Sell 17.5 -7,712 -16.05% ✗ $1.2M
Feb 2, 2023 Feb 2, 2023 Woolson Daniel VP, GM-Infusion Capital Sell 17.5 -1,731 -15.91% ✓ $346.2K